TL
TriSalus Life Sciences, Inc.
TLSI · NASDAQ
$5.10 +3.87% (+$0.19)
1M -0.20%
Market Cap $314.0M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$3.2
37.3% downside
Trenutna cena
$5.1
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TLSI trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
8 /100
Expensive P/B 47.94x
P/S 6.97x
EV/FFO N/A
Growth
100 /100
Growing Rev. growth 53.85%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 67.68%
Gross margin 85.79%
FCF margin 66.34%
Quality
13 /100
Poor Asset turnover 0.72x
ROIC 59.25%
ROA 45.18%
Debt
23 /100
High Int. coverage -3.83x
Debt/Equity 5.26x
Current ratio 5.35x
Stability
57 /100
Moderate EPS volatility 50.74%
Beta 0.44x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TLSI
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Mary T. Szela
Employees
102
Headquarters
Westminster
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report